Company news
Optibiotix Health Plc (LSE:OPTI) news
Optibiotix Health Plc news releases on 6ix. Latest, Feb 9, 2024: Change of auditor
Press releases — page 2
Change of auditor
February 9, 2024
Presentation at ProBiota 2024
February 5, 2024
SweetBiotix Update
January 30, 2024
Launch of LeanBiome in Muscletech
January 15, 2024
Distribution agreement for SlimBiome
November 28, 2023
BBSRC Grant for WellBiome®
November 22, 2023
License agreement with Tata Chemicals
October 23, 2023
Planned launch of OptiBiotix products with Boots
September 22, 2023
SweetBiotix® overview
July 19, 2023
Issue of Equity - Subscription
December 5, 2022
Launch of GoFigure products on Tmall China
November 1, 2022
Approval of GoFigure products
October 24, 2022
New health claims for SlimBiome in Australia
October 17, 2022
Launch of novel prebiotic in Europe and Africa
September 26, 2022
Launch of GoFigure range with Apollo Hospitals
September 20, 2022
New commercialisation partner in Asia Pacific
September 14, 2022
Second Price Monitoring Extn
August 24, 2022
Price Monitoring Extension
August 24, 2022
Commercial and scientific update
July 20, 2022
Joint development agreement signed with Firmenich
July 11, 2022
Director Appointment and Director Dealing
July 1, 2022
ProBiotix Health - Appointment of CEO
June 20, 2022
Admission of ProBiotix Health plc to AQSE
March 31, 2022
Intention to list ProBiotix Health on AQSE
March 17, 2022
Exercise of warrants
March 9, 2022
Commercial Appointments
March 1, 2022
Trading Update
February 28, 2022
Commercial and strategy update
February 9, 2022
Consumer study of LPLDL in Cholbiome products
February 1, 2022
Exercise of Warrants
January 27, 2022
Publication of third human study on LPLDL
January 18, 2022
Issue of options
January 7, 2022
OptiBiotix obtains BRC accreditation
January 5, 2022
Exclusive sales and distribution agreement
December 15, 2021
Investor presentation
December 1, 2021
Launch of LeanBiome with global nutrition leader
December 1, 2021
Formation of OptiBiotix Health India
November 17, 2021
SlimBiome® Approved by Health Canada
October 25, 2021
Director dealing
August 31, 2021
Extension of territories for Seed Health's DS-01
August 10, 2021
Trading and commercial update
August 5, 2021
Further sales expansion in Asia
July 6, 2021
SkinBioTherapeutics plc shareholding
May 19, 2021
Director's Dealing
April 16, 2021
Directorate Changes
March 23, 2021
Commercial strategy update
March 17, 2021
Director Appointment
March 2, 2021
Strategy and commercial update
February 18, 2021
Proposed Director appointment
February 2, 2021
New appointments
January 19, 2021